RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of RNAimmune's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines.  

Biotechnology

RNAimmune

Dong Shen

Kevin Bong

Ezra Myung Chul Chung

David Brown

Lori Knoche

JiaXi He

RNAimmune's Leadership Team includes Dong Shen.

Leadership Team

About

Team members